Evidence map›Paper›PMID 40767879›Full record

ArticleMikrochimica acta2025

Fluorescent sensing of tsRNA by silver nanoclusters with exponential amplification-mediated DNA tetrahedron.

Haiping Fan, Qianyu Chen, Guoer Tang, Zicheng Huang, Wei Li, Xueping Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haiping Fan *Department of Clinical Laboratory, Chongqing Emergency Medical center, Chongqing University Central Hospital, School of Medicine, Chongqing University, Chongqing, 400014, People's Republic of China.
Qianyu Chen *The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Guoer TangThe First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Zicheng HuangThe First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Wei LiDepartment of Clinical Laboratory, Chongqing Emergency Medical center, Chongqing University Central Hospital, School of Medicine, Chongqing University, Chongqing, 400014, People's Republic of China. liwei0111@cqu.edu.cn.
Xueping ChenThe Center for Clinical Molecular Medical Detection, Laboratory Medicine Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China. cxphz2012@163.com.

Funding

Chongqing Science and Technology Bureau NO. CSTB2024TIAD-CYKJCXX0038
6 · The paper itself

Abstract

Transfer RNA (tRNA)-derived small RNAs (tsRNAs) are crucial regulators and potential biomarkers for various cancers, including breast cancer, due to their stability and specific expression in tumor tissues. However, current detection methods face limitations like complex instrumentation and low sensitivity, highlighting the urgent need for the development of rapid and reliable detection platforms for tsRNAs. The EXPAR reaction could amplify the tsRNA by several orders of magnitude into another oligo sequence. The amplified oligos can undergo a toehold-mediated strand displacement reaction (TMDR) with the blocked sequence on one edge of the DNA tetrahedron, exposing a poly C sequence capable of forming a stem-loop structure. During this process, the DNA tetrahedron provides structural stability. The exposed polyC sequence efficiently facilitates the synthesis of silver nanoclusters, enabling the detection of tsRNA through fluorescence signals. Under the optimal condition, the method achieved a detection limit as low as 41.21 fM. Validation using clinical samples from breast cancer patients showed strong correlation with qRT-PCR results, confirming the clinical utility of the platform. The proposed EXPAR-DTH platform addressed the key limitations of current tsRNA detection technologies by offering a highly sensitive, cost-effective, and easy-to-implement method. Its success in clinical sample analysis highlighted its potential for use in cancer diagnostics, particularly in point-of-care settings.

Indexed as

DNAMetal NanoparticlesNucleic Acid Amplification TechniquesRNA, TransferSilverBiosensing TechniquesBreast NeoplasmsFemaleFluorescenceFluorescent DyesHumansLimit of DetectionSpectrometry, FluorescenceDNAFluorescent DyesRNA, TransferSilverAgNCsBreast cancer biomarkerDTHEXPARFluorescent detectionTsRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.